Literature DB >> 19132774

Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands.

Anne F van Rijn1, Paul Fockens, Peter D Siersema, Bas Oldenburg.   

Abstract

AIM: To study adherence to the widely accepted surveillance guidelines for patients with long-standing colitis in The Netherlands.
METHODS: A questionnaire was sent to all 244 gastroenterologists in The Netherlands.
RESULTS: The response rate was 63%. Of all gastroenterologists, 95% performed endoscopic surveillance in ulcerative colitis (UC) patients and 65% in patients with Crohn's colitis. The American Gastroenterological Association (AGA) guidelines were followed by 27%, while 27% and 46% followed their local hospital protocol or no specific protocol, respectively. The surveillance was correctly initiated in cases of pancolitis by 53%, and in cases of left-sided colitis by 44% of the gastroenterologists. Although guidelines recommend 4 biopsies every 10 cm, less than 30 biopsies per colonoscopy were taken by 73% of the responders. Only 31%, 68% and 58% of the gastroenterologists referred patients for colectomy when low-grade dysplasia, high-grade dysplasia (HGD) or Dysplasia Associated Lesion or Mass (DALM) was present, respectively.
CONCLUSION: Most Dutch gastroenterologists perform endoscopic surveillance without following international recommended guidelines. This practice potentially leads to a decreased sensitivity for dysplasia, rendering screening for colorectal cancer in this population highly ineffective.

Entities:  

Mesh:

Year:  2009        PMID: 19132774      PMCID: PMC2653310          DOI: 10.3748/wjg.15.226

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

1.  Reported response rates to mailed physician questionnaires.

Authors:  S M Cummings; L A Savitz; T R Konrad
Journal:  Health Serv Res       Date:  2001-02       Impact factor: 3.402

2.  How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance.

Authors:  J A Eaden; B A Ward; J F Mayberry
Journal:  Gastrointest Endosc       Date:  2000-02       Impact factor: 9.427

3.  Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

Authors:  J A Eaden; J F Mayberry
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

4.  Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2004-07       Impact factor: 10.864

5.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

6.  Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.

Authors:  J Eaden; K Abrams; H McKay; H Denley; J Mayberry
Journal:  J Pathol       Date:  2001-06       Impact factor: 7.996

7.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.

Authors:  Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

8.  Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis.

Authors:  C N Bernstein; W M Weinstein; D S Levine; F Shanahan
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

9.  Increased risk of large-bowel cancer in Crohn's disease with colonic involvement.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

10.  Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome.

Authors:  D M Melville; J R Jass; B C Morson; D J Pollock; P I Richman; N A Shepherd; J K Ritchie; S B Love; J E Lennard-Jones
Journal:  Hum Pathol       Date:  1989-10       Impact factor: 3.466

View more
  18 in total

1.  Endoscopy in inflammatory bowel disease when and why.

Authors:  Rajaratnam Rameshshanker; Naila Arebi
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

Review 2.  Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.

Authors:  Samir A Shah; David T Rubin; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2014-09

Review 3.  Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis.

Authors:  Devendra Desai; Nutan Desai
Journal:  World J Gastrointest Endosc       Date:  2014-11-16

Review 4.  Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.

Authors:  Eun Ran Kim; Dong Kyung Chang
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice-results of a non-representative survey.

Authors:  Lea I Kredel; Oliver Schneidereit; Jörg C Hoffmann; Britta Siegmund; Jan C Preiß
Journal:  Int J Colorectal Dis       Date:  2018-12-07       Impact factor: 2.571

6.  Colorectal cancer surveillance in patients with inflammatory bowel disease: What is new?

Authors:  Danila Guagnozzi; Alfredo J Lucendo
Journal:  World J Gastrointest Endosc       Date:  2012-04-16

Review 7.  Colorectal cancer in inflammatory bowel disease: review of the evidence.

Authors:  D S Keller; A Windsor; R Cohen; M Chand
Journal:  Tech Coloproctol       Date:  2019-01-30       Impact factor: 3.781

Review 8.  Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.

Authors:  Parambir S Dulai; William J Sandborn; Samir Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-27

Review 9.  Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?

Authors:  Mariabeatrice Principi; Michele Barone; Maria Pricci; Nicola De Tullio; Giuseppe Losurdo; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

10.  Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease.

Authors:  M W M D Lutgens; B Oldenburg; P D Siersema; A A van Bodegraven; G Dijkstra; D W Hommes; D J de Jong; P C F Stokkers; C J van der Woude; F P Vleggaar
Journal:  Br J Cancer       Date:  2009-10-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.